169 related articles for article (PubMed ID: 1376759)
1. [Combination chemotherapy with 254-S, ifosfamide and peplomycin for advanced or recurrent cervical cancer].
Hirabayashi K; Okada E; Nakazuma Y; Akamatsu Y; Sezaki H; Ohta M; Nakanishi Y
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Mar; 44(3):341-8. PubMed ID: 1376759
[TBL] [Abstract][Full Text] [Related]
2. [Combination chemotherapy with nedaplatin, bleomycin and ifosfamide for advanced cervical cancer of the uterus--a preliminary study for phase III clinical study].
Noda K; Hirabayashi K; Terashima Y; Ozaki M; Yakushiji M; Hatae M; Kanazawa K
Gan To Kagaku Ryoho; 1997 Aug; 24(10):1285-93. PubMed ID: 9279348
[TBL] [Abstract][Full Text] [Related]
3. Chemotherapy with paclitaxel, ifosfamide, and cisplatin for the treatment of squamous cell cervical cancer: the experience of Monza.
Zanetta G; Fei F; Mangioni C
Semin Oncol; 2000 Feb; 27(1 Suppl 1):23-7. PubMed ID: 10697040
[TBL] [Abstract][Full Text] [Related]
4. [Neoadjuvant intraarterial chemotherapy with nedaplatin, peplomycin and mitomycin C for advanced cervical cancer].
Umeki H; Yamaguchi Y; Tsugata M; Wakana K; Somekawa Y; Shimabukuro K; Ohara M; Terauchi T; Ichimura M; Otsuka I; Aso T
Gan To Kagaku Ryoho; 2003 Mar; 30(3):377-82. PubMed ID: 12669397
[TBL] [Abstract][Full Text] [Related]
5. Combination chemotherapy with 254-S, ifosfamide, and peplomycin for advanced or recurrent cervical cancer.
Hirabayashi K; Okada E
Cancer; 1993 May; 71(9):2769-75. PubMed ID: 7682148
[TBL] [Abstract][Full Text] [Related]
6. [Long time survival after combination chemotherapy with cisplatin, vinblastine and peplomycin for cervical cancer].
Onishi Y; Hatae M; Hokanishi H
Nihon Sanka Fujinka Gakkai Zasshi; 1993 Jul; 45(7):657-64. PubMed ID: 7688016
[TBL] [Abstract][Full Text] [Related]
7. Ifosfamide, adriamycin and cisplatin (IAP) plus bleomycin (B) combination chemotherapy in patients with recurrent cancer of the uterine cervix.
Nishida T; Nagasue N; Arimatsu T; Nagano H; Izumi S; Okura N; Matsumura T; Yakushiji M
Nihon Sanka Fujinka Gakkai Zasshi; 1989 May; 41(5):590-4. PubMed ID: 2474043
[TBL] [Abstract][Full Text] [Related]
8. [Combination chemotherapy with PAP (peplomycin, adriamycin and cisplatin) in recurrent uterine cervical cancer with pulmonary metastasis].
Fujii M; Okabe K; Toki H; Araki Y; Masaoka H
Gan To Kagaku Ryoho; 1984 Feb; 11(2):342-3. PubMed ID: 6198971
[TBL] [Abstract][Full Text] [Related]
9. Lomustine (chloroethylnitrosourea [CCNU]), ifosfamide, bleomycin, vincristine, and cisplatin (CIBO-P) is an effective regimen for patients with poor prognostic refractory or multiple disease recurrent aggressive non-Hodgkin lymphoma.
Musolino A; Perrone MA; Michiara M; Delnevo D; Franciosi V; Di Blasio B; Ceci G; Camisa R; Ardizzoni A; Cocconi G
Cancer; 2005 May; 103(10):2109-17. PubMed ID: 15803492
[TBL] [Abstract][Full Text] [Related]
10. [Treatment of advanced or recurrent cervical cancer by a new BOMP regimen consisting of bleomycin, vincristine, mitomycin-C, and low-dose consecutive cisplatin].
Shimizu Y; Nakayama K; Seimiya Y; Yamakawa Y; Koi S; Yokosuka K; Teshima H; Chen JT; Fujimoto I; Yamauchi K
Nihon Sanka Fujinka Gakkai Zasshi; 1991 May; 43(5):549-56. PubMed ID: 1711555
[TBL] [Abstract][Full Text] [Related]
11. The role of ifosfamide in cervical cancer.
Buxton EJ; Blackledge G; Mould JJ; Monaghan J; Paterson M; Tobias J; Alcock C; Spooner D; Meanwell CA
Semin Oncol; 1989 Feb; 16(1 Suppl 3):60-7. PubMed ID: 2468183
[TBL] [Abstract][Full Text] [Related]
12. Bleomycin, cisplatinum and ifosfamide infusion chemotherapy in advanced/recurrent cancer of cervix.
Singhal RM; Jindel R; Gupta AK
Indian J Cancer; 1993 Dec; 30(4):158-63. PubMed ID: 7515843
[TBL] [Abstract][Full Text] [Related]
13. [Neoadjuvant chemotherapy for advanced cervical cancer].
Kodama J; Ikuhashi H; Hongo A; Mizutani Y; Miyagi Y; Yoshinouchi M; Kobashi Y; Okuda H; Kudo T
Gan To Kagaku Ryoho; 1999 Jan; 26(1):89-92. PubMed ID: 9987503
[TBL] [Abstract][Full Text] [Related]
14. [The course of squamous cell carcinoma antigen and CEA as prognostic criteria for response to chemotherapy in cervix cancer].
Meier W; Eiermann W; Stieber P; Fateh-Moghadam A; Hepp H
Geburtshilfe Frauenheilkd; 1989 Dec; 49(12):1050-5. PubMed ID: 2693187
[TBL] [Abstract][Full Text] [Related]
15. Neoadjuvant intraarterial chemotherapy followed by radical hysterectomy and/or radiotherapy for locally advanced cervical cancer.
Sugiyama T; Nishida T; Hasuo Y; Fujiyoshi K; Yakushiji M
Gynecol Oncol; 1998 May; 69(2):130-6. PubMed ID: 9600820
[TBL] [Abstract][Full Text] [Related]
16. Cisplatin, 5-fluorouracil, and ifosfamide in the treatment of recurrent or advanced cervical cancer.
Fanning J; Ladd C; Hilgers RD
Gynecol Oncol; 1995 Feb; 56(2):235-8. PubMed ID: 7896191
[TBL] [Abstract][Full Text] [Related]
17. Results of concomitant chemoradiation for cervical cancer using high dose rate intracavitary brachytherapy: study of JROSG (Japan Radiation Oncology Study Group).
Sakata K; Sakurai H; Suzuki Y; Katoh S; Ohno T; Toita T; Kataoka M; Tanaka E; Kaneyasu Y; Uno T; Harima Y; Nakano T;
Acta Oncol; 2008; 47(3):434-41. PubMed ID: 18348003
[TBL] [Abstract][Full Text] [Related]
18. [Combination chemotherapy with peplomycin, cis-platinum and mitomycin C in gynecologic cancer].
Yasui Y; Suzumori K; Asai H; Yagami Y
Gan No Rinsho; 1985 Sep; 31(11):1415-21. PubMed ID: 2415720
[TBL] [Abstract][Full Text] [Related]
19. Intravenous nedaplatin and intraarterial cisplatin with transcatheter arterial embolization for patients with locally advanced uterine cervical cancer.
Adachi S; Ogasawara T; Tsubamoto H; Oku H; Hori Y; Tsuji Y; Takemura T; Koyama K
Int J Clin Pharmacol Res; 2001; 21(3-4):105-10. PubMed ID: 12067139
[TBL] [Abstract][Full Text] [Related]
20. Bleomycin, methotrexate, and CCNU in locally advanced or recurrent, inoperable, squamous-cell carcinoma of the vulva: an EORTC Gynaecological Cancer Cooperative Group Study. European Organization for Research and Treatment of Cancer.
Wagenaar HC; Colombo N; Vergote I; Hoctin-Boes G; Zanetta G; Pecorelli S; Lacave AJ; van Hoesel Q; Cervantes A; Bolis G; Namer M; Lhommé C; Guastalla JP; Nooij MA; Poveda A; Scotto di Palumbo V; Vermorken JB
Gynecol Oncol; 2001 Jun; 81(3):348-54. PubMed ID: 11371121
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]